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CC BY-NC-ND license (http://creativeAbstract Breast tuberculosis is a rare form of extrapulmonary tubercular infection. Our aim
is to highlight the nonspecific clinical presentations, diagnostic difficulties and therapeutic ap-
proaches of mammarian tuberculosis. Forty-six patients diagnosed with breast tuberculosis be-
tween 2005 and 2015 were reviewed retrospectively. Clinical features, all diagnostic methods,
and the outcomes of treatment were analysed. All cases were female with a mean age of
36.4 years. Breast mass and pain were the most common complaints. While 34.8% of the cases
had a physical examination with suspicions for malignancy, 43.5% of the patients had Breast
Imaging Reporting and Data System (BI-RADS) 4 or 5 lesions suggested malignancy radiologi-
cally. Definitive diagnosis was based on histopathologic examination through core needle bi-
opsy (n Z 29), excisional biopsy (n Z 12), and open biopsy (n Z 5) taken from the abscess
wall during drainage. Standard antiTB therapy for 6 months was given to all cases. Thirty-
three patients recovered with standard 6-month therapy while extended treatment for 9
e12 months was needed in 13 (28.2%) cases. Surgery was carried out in 17 cases. Two patients
developed recurrence. Breast tuberculosis can be easily confused with breast cancer, suppu-
rative abscess, and other causes of granulomatous mastitis, both clinically and radiologically.
A multidisciplinary approach is required to prevent diagnostic delays and unnecessary surgical
interventions. Although antiTB therapy is the mainstay treatment of breast TB, surgery is usu-
ally indicated in patients refractory to medical treatment.
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Although Tuberculosis (TB) remains a major public health
problem with 1.3 million/year deaths globally [1], breast
TB, first described by Sir Astley Cooper in the 1800s [2], is a
rare clinical entity with an estimated rate of 0.025e1.04%
of all breast pathologies [3]. Breast TB is usually classified
as primary and secondary forms. Among these, the sec-
ondary form is seen more frequently, and usually associated
with various primary tubercular foci such as from the lungs,
pleura, or lymph nodes. Due to its rarity and variable
clinical presentations, breast TB can be confused with
other breast diseases such as breast carcinoma and pyo-
genic breast abscess, both clinically and radiologically [4].
Therefore, correct diagnosis of this uncommon disease is
usually based on high index of clinical suspicion. In this
paper, we aimed to analyze the clinical features, diagnostic
difficulties, and therapeutic outcomes of breast TB, in one
of the largest series on this topic in the literature.
Materials and methods
Patients
The medical records of 46 breast TB patients who were
treated between 2005 and 2015 at Yenimahalle/Ankara
Tuberculosis Control Dispensary (TCD) were reviewed
retrospectively. Approval of the ethics committee was ob-
tained from the Ministry of Health. Informed consents of
the patients were waived due to the retrospective nature
of the study. Patients’ demographic data such as age,
gender, marital status, employment status, educational
status, past and contact history of TB, comorbid diseases,
the initial clinical findings, radiological investigations
including breast ultrasonography (US) and mammography
(MM) were recorded. All patients were also evaluated in
terms of coexisting pulmonary TB, with chest X-ray and
culture of respiratory secretion.
Diagnosis
The breast TB diagnosis was mainly made based on histo-
pathological findings from core needle biopsy, excisional
biopsy of the abscess wall during drainage. Smear and
culture of breast tissue or discharge were also other
methods in the diagnostic workup. The histopathological
findings of epithelioid cell granulomas, Langhans’ giant
cells, and lymphohistiocytic aggregates confirmed the
diagnosis.
Treatment and follow-up
All patients were treated with isoniazid (5 mg/kg day, max.
300 mg/day) and rifampicin [10 mg/kg day, maximum (max)
600 mg/day] for 6 months. In the first 2-month period,
pyrazinamide (20e30 mg/kg day, max. 2 g/day) and
streptomycin (15 mg/kg day, max. 1 g/day) or ethambutol
(15e20 mg/kg day, max. 1.5 g/day) were administered. All
patients were evaluated at the end of the therapy, and if
there was no full resolution of symptoms andMycobacterium tuberculosis was still present in any spec-
imen, a treatment of 3 months was added. Patients were
invited at regular intervals after the end of the treatment.
All complications during the follow up period were
recorded.
Statistical assessment
The statistical package for social science (SPSS 21.0 IL,
Chicago, USA) standard version was used for data analyses.
Descriptive analysis was done for demographic, clinical,
and radiographic features. The results are presented as
mean  SD/percentages for continuous variables and
number/percentage for categorical variables. Chi-square
(c2) test, Fisher’s Exact test, and ManneWhitney U-test
were used to test for the significance of association be-
tween the two antiTB treatment groups (patients who
healed with standard antiTB therapy for 6 months and those
who needed extended therapy of 9e12 months). A signifi-
cance level was accepted as p < 0.05.
Results
Among the 1622 TB patients who were treated at Yenima-
halle TCD, we found 51 (3.1%) breast TB cases. Five of those
were excluded from the study due to irregular medical
records, and therefore data of 46 patients were analyzed.
All cases were female with a mean age of 36.4 years. All
demographic and clinical data of the patients are presented
in Table 1.
The mean duration of symptoms prior to admission was
35.5 days (range 0e180). The most common presenting
symptoms were breast lump (34, 73.9%) and pain (19,
41.3%). Clinically apparent breast abscess was the initial
presentation in five (10.9%) cases. The left breast was more
frequently affected than the right breast (Table 2).
Breast US was the first step radiological investigation in
all patients while mammography could be performed in 18
(39.1%) cases due to the limitation of age. Sonographic
examination of the breast revealed abnormal findings in the
majority of patients (91.3%). All the radiological findings
are presented in Table 3.
Definitive diagnosis was mainly based on histopatholog-
ical examination in all patients. Core needle biopsy
(nZ 31) was the most frequently used diagnostic tool, with
an accuracy rate of 93.5%. In cases of inconclusive core
needle biopsy (n Z 2) and small nonpalpable masses
(n Z 10), excisional biopsy with wide margins was per-
formed for the diagnosis. Open biopsy taken from the ab-
scess wall during drainage was carried out in five patients.
Epitheloid cell granulomas with or without caseous necrosis
and multinucleated giant cells were the leading histo-
pathological findings. All specimens were also subjected to
culture and ZiehleNielsen staining for identifying M.
tuberculosis. Culture of breast tissue and acid-fast bacilli
(AFB) staining were positive in 19.5% (9/46) and 8.7% (4/46)
patients, respectively. In addition, nine patients had smear
examination of discharge (from nipple or fistula), and pos-
itive Ziehl Nelsen staining was obtained in five of those.
Polymerase chain reaction (PCR) analysis could be done in
only four patients with 50% positivity.
Table 1 Baseline characteristics of patients (n Z 46).
Patient characteristics n (%)









Primary/secondary school 27 (58.7%)








Presence of comorbid disease
(except TB)
4 (8.7%)
History of pregnancy 43 (93.5%)
Pregnancy at the time of diagnosis
History of breastfeeding 41 (89.1%)
Active breastfeeding 6 (13%)
History of oral contraceptives use 2 (4.3%)
Coexisting pulmonary TB 3 (6.5%)
Past history of TB 5 (10.9%)
Contact history of TB 7 (15.2%)
Presence of BCG vaccination 45 (97.8%)
PPD positivity 41 (89.1%)
BCG Z bacillus CalmetteeGue´rin; TB Z tuberculosis;
PPD Z purified protein derivative.
Table 2 Presenting symptoms and signs of the patients
with breast TB.
Clinical findings n (%)
Presenting symptoms and findings
Breast lump with sinuses 7 (15.2%)
Breast lump without sinuses 27 (58.7%)
Breast pain with nodularity 10 (21.7%)
Breast pain without nodularity 9 (19.5%)
Sinus formation 10 (21.7%)
Nipple discharge 8 (17.4%)
Axillary lymphadenopathy 8 (17.4%)
Fever 2 (4.3%)
Incidental 3 (6.5%)









Retroareolar (central) 1 (2.2%)
More than one quadrant 16 (34.8%)
Clinical suspicion of malignancy 16 (34.8%)
TB Z tuberculosis.
Table 3 Radiological findings of the patients with breast
TB.
Radiologic findings n (%)
Chest X-ray (n Z 46)
Sequelae findings * of past TB 3 (6.5%)
Radioopacity 2 (4.3%)
Pleural effusion 1 (2.2%)
Normal 40 (87.0%)
Ultrasonographic findings (n Z 46)
Hypoechoic mass with irregular border 26 (56.5%)
Nonspecific inflammatory changes 18 (39.1%)
Axillary lymphadenopathy 9 (19.6%)
Abscess 5 (11.0%)
Well-defined mass 1 (2.2%)
Normal 4 (8.6%)
Mammographic findings (n Z 18)
Asymmetric density or poorly defined mass 10 (21.7%)
Distortion 5 (10.9%)
Microcalcification only 2 (4.3%)
Evaluation of 46 patients with breast tuberculosis 29All patients received standard antiTB therapy for
6 months. Thirty-three patients healed with standard 6-
month therapy while extended treatment for 9e12 months
was needed in 13 (28.2%) who had discontinued drug ther-
apy and had persistent symptoms and signs. There were no
statistical differences between the patients who healed
with standard 6-month antiTB therapy and the patients who
needed extended treatment, in terms of clinicopatholog-
ical features (p > 0.05). Surgery was carried out in 17 cases,
including total excision of mass for 12 patients and
repeated aspirations of abscess in five patients. Two of the
46 patients developed recurrence during the follow up
period. Recurrent lesions were in mass formations in both
patients, and were totally excised. Then, these two pa-
tients were treated with antiTB therapy for 8 months
(2H3R3Z3E3S3 þ 1H3R3Z3E3 þ 5H3R3E3). No recurrence was
observed during their follow-up periods.Spiculated mass 2 (4.3%)





* Calcified parenchymal nodules, calcified radiological scars,
calcified hilar lymph nodes, and etc.Discussion
Breast TB generally affects women of reproductive age
group; however, it can be also seen in young girls, elderly
women, and males [5]. Our study population completely
consisted of female patients with a mean age of 36.4 years,
30 M.O. Kilic et al.and only six cases were in their postmenopausal periods.
Although secondary form of breast TB has been more
frequently reported than primary form [6], 32% of the pa-
tients had coexisting pulmonary TB, past or contact history
of TB in the present study. However, it should be noted
here that the primary focus cannot be usually detected
radiologically or clinically [7]. In our opinion, presence of
coexisting pulmonary TB, past and contact history of TB
should be always investigated in the initial evaluation of
patients with breast TB. While the primary form of the
disease occurs via infection through skin abrasions or
openings of the lacrimal ducts at the nipple, secondary
form develops through three ways, including direct exten-
sion, hematogenously from the lung TB, and retrograde
lymphatic dissemination from the affected axillary lymph
nodes.
Various risk factors such as multiparity, lactation, and
pregnancy have been reported in the etiopathogenesis of
breast TB [7e9]. Among those, presence of lactation seems
to be more associated with the development of breast TB,
with a reported incidence rate of up to 30% [10]. This
condition may be explained by increased vascularity of the
breasts during lactation and lacerations at the areola,
which make the breast more vulnerable to tubercular
infection. In our study, while 13% of the patients were
lactating at their first admissions, only three patients were
pregnant. However, most of the cases were multiparous
and had prior history of breastfeeding.
Breast TB usually has unilateral involvement, and both
sides seem to be affected equally [4,11]. In the present
study, the majority of the patients had left breast lesion,
and bilateral involvement was observed in only one patient.
Additionally, upper outer quadrant of the breast is the most
common location in our patients, consistent with the pre-
vious studies [12,13]. Multicentric presentation was also
frequent in the study population.
The patients with breast TB are often symptomatic prior
to diagnosis for several weeks or months. The mean dura-
tion of symptoms in the present study was similar to other
many case series [6,8,10].
According to the clinical, radiological, and pathological
findings, breast TB can be classified as nodular, dissemi-
nated, and sclerosing forms [14]. Sclerosing type, charac-
terized by extensive fibrosis, is rare and often found in
elderly women [15]. While the disseminated form is char-
acterized by multiple lesions associated with sinus forma-
tion, nodular form is reported to be the principal clinical
manifestation that is characterized by a well defined,
painless, slow growing mammarian mass [16]. Similarly,
breast mass and pain were the most common physical
findings in our case series. However, physical examination
of the breast was consistent with malignancy in a significant
number of patients. Multiple sinuses with or without
discharge, ulcers, nipple or skin retraction, and discharge
from the nipple can be accompanied with the breast lump.
Ipsilateral axillary lymph node involvement is found in
approximately onethird of patients with breast TB [15,17].
In our work, approximately onefifth of the patients had
ipsilateral enlarged axillary lymph nodes, consistent with
these previous reports. Abscess formation may be the initial
clinical presentation in a small number of patients [17]. In
accordance, 11% of our study population presented with afluctated mammarian abscess as initial complaint. Due to
the variable presentations, breast TB is often confused with
malignancy and pyogenic breast abscess clinically.
Breast TB has also nonspecific radiological findings. US is
often used as the first step imaging method which shows
heterogeneous hypoechoic lesion with irregular borders and
internal echoes in most of the cases with breast TB. How-
ever, nonspecific stromal coarsening, asymmetric density,
and ill-defined nodules are among the most common
mammographic findings, which are not specific to breast
TB. Additionally, both MM and US are of limited value as the
findings are often indistinguishable from other differential
diagnoses such as breast carcinoma [6]. In our work, US was
used in all patients; however, MM was the choice of imaging
modality only for 18 cases > 35 years of age. The radio-
logical findings of our study population were also in parallel
with the data in the literature, and approximately half of
the cases had radiologically suspected lesions.
Mantoux test is often positive in patients from endemic
areas for TB, therefore may not be helpful in the diagnosis
of breast TB [18]. Additionally, high false positivity rate of
this test in BCG-vaccinated people due to cross reaction
with bacillus CalmetteeGue´rin (BCG) limits its widespread
use. In the present study, most of the patients had positive
Mantoux test, and almost all of those patients had previ-
ously been vaccinated. Therefore, this test did not provide
any significant diagnostic value in our work.
Although detection of tuberculous bacille by Ziehl
Neelsen staining or culture is accepted as the gold standard
diagnostic method in breast TB [19], these tests have some
limitations. It is well known that culture of M. tuberculosis
requires a lot of time and frequently gives negative results
[7,20]. Similarly, low positivity rates of AFB staining have
been reported in previous studies [3,11]. Our results of AFB
staining and culture were also similar to these previous
reports. The other method, PCR, is known as a rapid diag-
nostic test, but its low sensitivity and high costs are the
disadvantages for its general use. However, it can be
considered in cases with negative culture results or for
differential diagnosis between other forms of granuloma-
tous mastitis. In the present study, PCR was used in only
four patients, and positive results were obtained from two.
As a result, definitive diagnosis was mainly based on his-
topathology by core biopsy and open (incisional or exci-
sional) biopsy in our study population. Although fine needle
aspiration cytology (FNAC) has been reported as a method
with high diagnostic yield, some authors concluded that
definitive diagnosis of breast TB may need a histological
confirmation by larger tissue samples because granuloma-
tous inflammation cannot be confidently differentiated by
FNAC [21]. In accordance, we usually used core needle bi-
opsy in the diagnostic algorithm, and obtained high diag-
nostic yield. It should be noted here that the recognition of
tuberculosis does not exclude concomitant cancer. In our
study, biopsy specimens revealed no cancer diagnosis.
Standard antiTB therapy for 6 months is accepted as a
main treatment modality with reported very high success
rates [15,22]. This standard regimen was also administered
all the patients in the present study. Extended therapy of
9e12 months was needed in 13 cases due to the incomplete
resolution of the symptoms. Surgical intervention is
generally indicated for drainage of breast abscess,
Evaluation of 46 patients with breast tuberculosis 31diagnosis of the lesion, and excision of residual sinuses or
masses. Segmental or total mastectomy may be indicated in
patients with extensive disease or poor response to antiTB
therapy [23]. In our study, the number of patients who
received extended antiTB therapy may be considered as
high. Incompatibility of the patients in drug intake may
have led to this situation because, there was no significant
differences between the patients who healed with standard
6-month antiTB therapy and the patients who received
extended treatment, in terms of all clinicopathological
characteristics.
In conclusion, isolated breast TB is an uncommon entity,
even in TB endemic areas. Diagnosis is usually based on high
degree of clinical suspicion. A multidisciplinary approach is
important to prevent diagnostic delays and unnecessary
surgical interventions. The principal differential diagnosis is
that of breast carcinoma. Other breast diseases such as
fatty necrosis, supurative abscess, and idiopathic granulo-
matous mastitis may be confused with breast TB, both
clinically and radiologically. Although antiTB therapy is the
mainstay treatment of breast TB, surgery may be required
for patients refractory to medical treatment.
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